| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.76 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |